Astellas Pharma Inc. (FRA:YPH)
Germany · Delayed Price · Currency is EUR 11.64
+0.32 (2.83%)
At close: Jan 30, 2026
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of €20.95 billion as of January 30, 2026. Its market cap has increased by 25.31% in one year.
Market Cap
20.95B
Enterprise Value
23.42B
Revenue
11.56B
Ranking
n/a
PE Ratio
29.12
Stock Price
€11.64
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 5.37B to 20.95B, an increase of 290.34%. That is a compound annual growth rate of 4.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 20.95B | 2.70% |
| Dec 30, 2025 | 20.39B | 21.07% |
| Dec 30, 2024 | 16.84B | -13.17% |
| Dec 29, 2023 | 19.40B | -25.24% |
| Dec 30, 2022 | 25.95B | -2.39% |
| Dec 30, 2021 | 26.58B | 13.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |